Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells (Q44675831)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells
scientific article

    Statements

    Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells (English)
    Fumiaki Koizumi
    Fumihiko Kanzawa
    Yutaka Ueda
    Yasuhiro Koh
    Shoji Tsukiyama
    Fumiko Taguchi
    Tomohide Tamura
    Nagahiro Saijo
    Kazuto Nishio
    1 January 2004
    464-472

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit